The current study aimed to determine the expression of hypoxic markers, including HIF-1α, CA9, GLUT1, and VEGF, in STS using immunohistochemistry, and to analyze the impact of overexpression on the clinicopathological features of tumor aggressiveness. The gene discussed is CA9; the disease is telomere syndrome.